Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study | LANCET ONCOLOGY |